News for ICL Group Ltd (ICL)

Discover insights on global corporations’ India plans from their earnings calls, highlighting expansion, partnerships, and growth opportunities in India.

PR NewswireTEL AVIV, Israel, May 21, 2025 TEL AVIV, Israel, May 21, 2025 /PRNewswire/ -- Israel Corporation Ltd. (TASE: ILCO) ("ILCO") announced today its

Operator: Good morning, ladies and gentlemen, and welcome to the ICL First Quarter 2025 Earnings Call. At this time, all lines are in listen-only mode.

ICL Group Ltd (NYSE:ICL) Q1 2025 Earnings Conference Call May 19, 2025 4:00 AM ETCompany ParticipantsPeggy Reilly Tharp - Vice President, Global Investor...

The following slide deck was published by ICL Group Ltd in conjunction with their 2025 Q1 earnings call.

ICL (ICL) announced its first-quarter revenue increase to $1.77 billion, compared to $1.74 billion in the same period last year. The company's improved performa

Summary: ICL Group reported robust earnings in Q1 with $1.8 billion in revenue. Analysts project a moderate downside from current stock prices. GuruFo

Summary ICL Group Ltd (ICL), a global leader in specialty minerals, announced its financial results for the first quarter ending March 31, 2025. The company rep

ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today reported its financial results for the first quarter ended March 31, 2025. Cons

ICL Group Ltd. (ICL) reports a year-over-year increase in first quarter sales to $1.8 billion. Adjusted EBITDA was $359 million, slightly down from $362

Camtek led the gains today but Teva and Elbit Systems lost ground.

Elbit Systems recovered some of the ground lost yesterday as Camtek led the declines.

ICL and the banks led the market higher today but Teva fell sharply.

The banks rose strongly today but Teva and ICL fell. The market will reopen Sunday after the Independence Day holiday.

The banks led the TASE lower today as Teva and Elbit bucked the market.

STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICLâ„¢) for vision correction

Camtek and NICE led the strong gains today but Elbit fell again.

ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today announced it plans to release first quarter 2025 results prior to the opening o

Teva and the banks led the declines today as ICL bucked the market.